52 related articles for article (PubMed ID: 38478170)
1. New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.
Zhao W; Liu Y; Yang Y; Wang L
BMC Cancer; 2024 May; 24(1):635. PubMed ID: 38783241
[TBL] [Abstract][Full Text] [Related]
2. MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1.
Zhao G; Liang J; Zhang Y; Shan G; Bian Y; Gu J; Zhan C; Ge D
Commun Biol; 2024 Jun; 7(1):680. PubMed ID: 38831092
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of myricetin against lung adenocarcinoma based on bioinformatics, in silico and in vitro experiments.
Hao P; Zhang C; Bian H; Li Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4089-4104. PubMed ID: 38015259
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming-driven homologous recombination and TCA cycle dysregulation contribute to poor prognoses in lung adenocarcinoma.
Xu Z; He D; Huang L; Deng K; Jiang W; Qin J; Zheng Z; Zheng T; Li S
J Cell Mol Med; 2024 Jun; 28(11):e18406. PubMed ID: 38822457
[TBL] [Abstract][Full Text] [Related]
5. HMGN1 loss sensitizes lung cancer cells to chemotherapy.
Wu X; Cai G; Feng J; Lin W
Sci Rep; 2024 May; 14(1):10386. PubMed ID: 38710740
[TBL] [Abstract][Full Text] [Related]
6. Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism.
Hou Y; Yang Z; Xiang B; Liu J; Geng L; Xu D; Zhan M; Xu Y; Zhang B
Sci Rep; 2024 May; 14(1):12406. PubMed ID: 38811809
[TBL] [Abstract][Full Text] [Related]
7. Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells.
Chen CY; Fang HY; Chiou SH; Yi SE; Huang CY; Chiang SF; Chang HW; Lin TY; Chiang IP; Chow KC
Cancer Sci; 2011 Aug; 102(8):1582-9. PubMed ID: 21554491
[TBL] [Abstract][Full Text] [Related]
8. FAM83B regulates mitochondrial metabolism and anti-apoptotic activity in pulmonary adenocarcinoma.
Wang J; Li P; Sun L; Zhang J; Yue K; Wang Y; Wu X
Apoptosis; 2024 Jun; 29(5-6):743-756. PubMed ID: 38478170
[TBL] [Abstract][Full Text] [Related]
9. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
10. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
11. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.
Chen Y; Tang J; Lu T; Liu F
Thorac Cancer; 2020 Jul; 11(7):1848-1860. PubMed ID: 32395869
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
Kang H; Ma D; Zhang J; Zhao J; Yang M
BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
[TBL] [Abstract][Full Text] [Related]
13. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
